Quarterly report pursuant to Section 13 or 15(d)


3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
The Company has interests in 174 partnership or joint venture entities. The limited liability companies and limited partnerships in which the Company is the general partner are generally engaged directly or indirectly in the acquisition, development, operation, and ownership of real estate. The accounting principles of these entities are substantially the same as those of the Company. Additionally, the Company has direct investments in several funds, including certain Bridge-sponsored funds. The Company’s investments are summarized below (in thousands):
Carrying Value
Investments March 31, 2023 December 31, 2022
Accrued performance allocations(1)
$ 447,698  $ 554,723 
Other investments:
Partnership interests in Company-sponsored funds(2)
162,247  65,289 
Investments in third-party partnerships(3)
12,003  11,798 
10,711  8,369 
Total other investments $ 184,961  $ 85,456 
(1)Represents various investment accounts held by the Bridge GP’s for carried interest in Bridge-sponsored funds. There is a disproportionate allocation of returns to the Company as general partner or equivalent based on the extent to which cumulative performance of the fund exceeds minimum return hurdles. Investment is valued using NAV of the respective vehicle, which are based on asset valuations one quarter in arrears.
(2)Partnership interests in Company-sponsored funds are valued using NAV of the respective vehicle.
(3)Investments in limited partnership interest in third-party private property technology venture capital firms are valued using NAV of the respective vehicle.
(4)Other investments are accounted for using the measurement alternative to measure at cost adjusted for any impairment and observable price changes.
The Company recognized a loss related to its accrued performance allocations and other investments of $102.4 million for the three months ended March 31, 2023 and income of $75.2 million for the three months ended March 31, 2022, of which a loss of $103.9 million and income of $74.8 million for three months ended March 31, 2023 and 2022, respectively, related to accrued performance allocations recognized under the equity method.
Of the total accrued performance allocations balance as of March 31, 2023 and December 31, 2022, $52.1 million and $66.8 million, respectively, were payable to affiliates and are included in accrued performance allocations compensation in the condensed consolidated balance sheets as of the periods then ended.
Fair value of the accrued performance allocations is reported on a three-month lag from the fund financial statements due to timing of the information provided by the funds and third-party entities unless information is available on a more-timely basis. As a result, any changes in the markets in which our managed funds operate, and the impact market conditions have on underlying asset valuations, may not yet be reflected in reported amounts.
The Company evaluates each of its equity method investments, excluding Accrued Performance Allocations, to determine if any were significant as defined by the SEC. As of March 31, 2023 and December 31, 2022, no individual equity method investment held by the Company met the significance criteria. As a result, the Company is not required to provide separate financial statements for any of its equity method investments.